Lurace 40mg Tablet contains Lurasidone 40mg, an atypical antipsychotic agent indicated for the treatment of schizophrenia and bipolar depression. Lurasidone exerts its therapeutic effects primarily through antagonism of dopamine D2 and serotonin 5-HT2A receptors, contributing to the modulation of neurotransmitter activity in the central nervous system. This medication is effective in reducing psychotic symptoms such as hallucinations, delusions, and disorganized thinking, as well as improving mood and cognitive function in affected patients. Lurace 40mg is generally administered orally once daily with food to enhance absorption and bioavailability. Common side effects may include nausea, akathisia, sedation, and extrapyramidal symptoms; however, it is typically well-tolerated when used as prescribed. Caution is advised in patients with a history of cardiovascular disease, seizures, or metabolic disorders, and regular monitoring of weight, glucose, and lipid profiles is recommended during prolonged therapy. Lurace should not be abruptly discontinued to avoid withdrawal symptoms or relapse. It is contraindicated in individuals with known hypersensitivity to lurasidone or its components. Use during pregnancy and lactation should be carefully considered against potential risks. Always consult a healthcare professional before initiating or adjusting treatment with Lurace 40mg Tablet.